Skip to main content

Publisher: Wiley-Blackwell on behalf of the International Society on Thrombosis and Haemostasis

Volume 9, Number 5, May 2011

Favourites:
ADD

Free Content Genetic determinants of von Willebrand factor levels and activity in relation to the risk of cardiovascular disease: a review
pp. 899-908(10)
Authors: VAN SCHIE, M. C.; VAN LOON, J. E.; DE MAAT, M. P. M.; LEEBEEK, F. W. G.

Favourites:
ADD

Free Content A case–control study on platelet reactivity in patients with coronary stent thrombosis
pp. 909-916(8)
Authors: BOUMAN, H. J.; VAN WERKUM, J. W.; BREET, N. J.; TEN CATE, H.; HACKENG, C. M.; TEN BERG, J. M.

Favourites:
ADD

Free Content Thalassemia trait and arterial thromboembolic events: a systematic review and a meta-analysis of the literature
pp. 917-921(5)
Authors: DENTALI, F.; ROMUALDI, E.; AGENO, W.; CAPPELLINI, M. D.; MANNUCCI, P. M.

Favourites:
ADD

Free Content Radiosynovectomy in hemophilia: quantification of its effectiveness through the assessment of 10 articular parameters
pp. 928-935(8)
Authors: DE LA CORTE-RODRIGUEZ, H.; RODRIGUEZ-MERCHAN, E. C.; JIMENEZ-YUSTE, V.

Favourites:
ADD

Free Content Recombinant ADAMTS13 normalizes von Willebrand factor-cleaving activity in plasma of acquired TTP patients by overriding inhibitory antibodies
pp. 936-944(9)
Authors: PLAIMAUER, B.; KREMER HOVINGA, J. A.; JUNO, C.; WOLFSEGGER, M. J.; SKALICKY, S.; SCHMIDT, M.; GRILLBERGER, L.; HASSLACHER, M.; KNÖBL, P.; EHRLICH, H.; SCHEIFLINGER, F.

Favourites:
ADD

Free Content Common large partial VWF gene deletion does not cause alloantibody formation in the Hungarian type 3 von Willebrand disease population
pp. 945-952(8)
Authors: MOHL, A.; BODA, Z.; JAGER, R.; LOSONCZY, H.; MAROSI, A.; MASSZI, T.; NAGY, E.; NEMES, L.; OBSER, T.; OYEN, F.; RADVÁNYI, G.; SCHLAMMADINGER, Á.; SZÉLESSY, ZS.; VÁRKONYI, A.; VEZENDY, K.; VILIMI, B.; SCHNEPPENHEIM, R.; BODÓ, I.

Favourites:
ADD

Free Content Decreased active von Willebrand factor level owing to shear stress in aortic stenosis patients
pp. 953-958(6)
Authors: HOLLESTELLE, M. J.; LOOTS, C. M.; SQUIZZATO, A.; RENNÉ, T.; BOUMA, B. J.; DE GROOT, P. G.; LENTING, P. J.; MEIJERS, J. C. M.; GERDES, V. E. A.

Favourites:
ADD

Free Content Homozygous F5 deep-intronic splicing mutation resulting in severe factor V deficiency and undetectable thrombin generation in platelet-rich plasma
pp. 959-968(10)
Authors: CASTOLDI, E.; DUCKERS, C.; RADU, C.; SPIEZIA, L.; ROSSETTO, V.; TAGARIELLO, G.; ROSING, J.; SIMIONI, P.

Favourites:
ADD

Free Content High levels of protein C are determined by PROCR haplotype 3
pp. 969-976(8)
Authors: PINTAO, M. C.; ROSHANI, S.; DE VISSER, M. C. H.; TIEKEN, C.; TANCK, M. W. T.; WICHERS, I. M.; MEIJERS, J. C. M.; ROSENDAAL, F. R.; MIDDELDORP, S.; REITSMA, P. H.

Favourites:
ADD

Free Content Stressed fibrin lysis
pp. 977-978(2)
Author: WEISEL, J. W.

Favourites:
ADD

Free Content Hindered dissolution of fibrin formed under mechanical stress
pp. 979-986(8)
Authors: VARJÚ, I.; SÓTONYI, P.; MACHOVICH, R.; SZABÓ, L.; TENEKEDJIEV, K.; SILVA, M. M. C. G.; LONGSTAFF, C.; KOLEV, K.

Favourites:
ADD

Free Content Enhancement of fibrinolysis by inhibiting enzymatic cleavage of precursor α2-antiplasmin
pp. 987-996(10)
Authors: LEE, K. N.; JACKSON, K. W.; CHRISTIANSEN, V. J.; DOLENCE, E. K.; MCKEE, P. A.

Favourites:
ADD

Free Content A synthetic peptide derived from staphylokinase enhances plasminogen activation by tissue-type plasminogen activator
pp. 997-1006(10)
Authors: OKADA, K.; UESHIMA, S.; MATSUNO, H.; NAGAI, N.; KAWAO, N.; TANAKA, M.; MATSUO, O.

Favourites:
ADD

Free Content EMMPRIN (CD147/basigin) mediates platelet–monocyte interactions in vivo and augments monocyte recruitment to the vascular wall
pp. 1007-1019(13)
Authors: SCHULZ, C.; VON BRÜHL, M.-L.; BAROCKE, V.; CULLEN, P.; MAYER, K.; OKROJEK, R.; STEINHART, A.; AHMAD, Z.; KREMMER, E.; NIESWANDT, B.; FRAMPTON, J.; MASSBERG, S.; SCHMIDT, R.

Favourites:
ADD

Free Content Effects of in vitro adult platelet transfusions on neonatal hemostasis
pp. 1020-1028(9)
Authors: FERRER-MARIN, F.; CHAVDA, C.; LAMPA, M.; MICHELSON, A. D.; FRELINGER, A. L.; SOLA-VISNER, M.

Favourites:
ADD

Free Content Glycogen synthase kinase-3 negatively regulates tissue factor expression in monocytes interacting with activated platelets
pp. 1029-1039(11)
Authors: DI SANTO, A.; AMORE, C.; DELL'ELBA, G.; MANARINI, S.; EVANGELISTA, V.

Favourites:
ADD

Free Content Bleeding tendency and impaired platelet function in a patient carrying a heterozygous mutation in the thromboxane A2 receptor
pp. 1040-1048(9)
Authors: KAMAE, T.; KIYOMIZU, K.; NAKAZAWA, T.; TADOKORO, S.; KASHIWAGI, H.; HONDA, S.; KANAKURA, Y.; TOMIYAMA, Y.

Favourites:
ADD

Free Content Red blood cell phosphatidylserine exposure is responsible for increased erythrocyte adhesion to endothelium in central retinal vein occlusion
pp. 1049-1055(7)
Authors: WAUTIER, M.-P.; HÉRON, E.; PICOT, J.; COLIN, Y.; HERMINE, O.; WAUTIER, J.-L.

Favourites:
ADD

Free Content Immunophenotypic characterization of human monocyte subsets: possible implications for cardiovascular disease pathophysiology
pp. 1056-1066(11)
Authors: SHANTSILA, E.; WRIGLEY, B.; TAPP, L.; APOSTOLAKIS, S.; MONTORO-GARCIA, S.; DRAYSON, M. T.; LIP, G. Y. H.

Favourites:
ADD

Free Content Age at first joint bleed and bleeding severity in boys with severe hemophilia A: Canadian Hemophilia Primary Prophylaxis Study
pp. 1067-1069(3)
Authors: HANG, M. X.; BLANCHETTE, V. S.; PULLENAYEGUM, E.; MCLIMONT, M.; FELDMAN, B. M.

Favourites:
ADD

Free Content GlycoPEGylated rFVIIa (N7-GP) has a prolonged hemostatic effect in hemophilic mice compared with rFVIIa
pp. 1070-1072(3)
Authors: HOLMBERG, H.; ELM, T.; KARPF, D.; TRANHOLM, M.; BJØRN, S. E.; STENNICKE, H.; EZBAN, M.

Favourites:
ADD

Free Content Endogenous protein C inhibits activation of coagulation and transiently lowers bacterial outgrowth in murine Escherichia coli peritonitis
pp. 1072-1074(3)
Authors: SCHOUTEN, M.; VAN'T VEER, C.; LEVI, M.; ESMON, C. T.; VAN DER POLL, T.

Favourites:
ADD
Favourites:
ADD

Free Content Soluble thrombomodulin in coronary heart disease: lack of an association in the MONICA/KORA case–cohort study
pp. 1078-1080(3)
Authors: KARAKAS, M.; BAUMERT, J.; HERDER, C.; ROTTBAUER, W.; MEISINGER, C.; KOENIG, W.; THORAND, B.

Favourites:
ADD

Free Content Prognostic relevance of an asymptomatic venous thromboembolism in patients with cancer
pp. 1081-1083(3)
Authors: DENTALI, F.; AGENO, W.; PIERFRANCESCHI, M. G.; IMBERTI, D.; MALATO, A.; NITTI, C.; SALVI, A.; SIRAGUSA, S.; SQUIZZATO, A.; VITALE, J.; AGNELLI, G.

Favourites:
ADD

Free Content Large deletions identified in patients with von Willebrand disease using multiple ligation-dependent probe amplification
pp. 1083-1086(4)
Authors: YADEGARI, H.; DRIESEN, J.; HASS, M.; BUDDE, U.; PAVLOVA, A.; OLDENBURG, J.

Favourites:
ADD

Free Content Screening for von Willebrand disease in children: a case–control study
pp. 1086-1089(4)
Authors: BUJNICKI, H. C.; SIDONIO, R. F.; KEMPTON, C.; KOUIDES, P. A.; KULKARNI, R.; NUGENT, D. J.; YEE, D. L.; MOORE, C. G.; RAGNI, M. V.

Favourites:
ADD
Favourites:
ADD

Free Content Join ISTH
pp. 1096-1096(1)

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more